Isolated haemorrhagic brain metastasis from lung adenocarcinoma in a 68-year-old man

Journal of the Hong Kong College of Radiologists

Volumn 7, Issue 3, 2004, Pages 140-144

  Ching, A S C ^a   Chan, P N ^a   Ng, H K ^a   Tse, K M ^b   Chan, Y L ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b St Teresa's Hospital   (Hong Kong)

Author keywords

Adenocarcinoma; Brain neoplasms; Cerebral hemorrhage diagnosis; Lung neoplasms; Radionuclide imaging

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE; GADOLINIUM;

AGED; AMNESIA; ANAMNESIS; ARTICLE; BLEEDING; BRAIN METASTASIS; CANCER EPIDEMIOLOGY; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HISTOLOGY; HUMAN; LUNG ADENOCARCINOMA; MALE; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE CARE; RADIOLOGY DEPARTMENT; TREATMENT OUTCOME;

EID: 20044364205     PISSN: 10295097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jeong HJ, Chung JK, Kim YK, et al. Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors. J Nucl Med 2002;43:1432-1437.
2. Loevner LA. Case review brain imaging. 1st ed. St Louis: Mosby; 1999:47-48.
3. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002; 94:2698-2705.
4. Hartshorne MF. Positron emission tomography. In: Orrison WW, Lewine JD, Sanders JA, Hartshorne MF, editors. Functional brain imaging. 1st ed. St Louis: Mosby; 1995:187-213.
5. Rohren EM, Provenzele JM, Barboriak DP, Coleman RE. Screening for cerebral metastasis with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy. Radiology 2003;226:181-187.
6. Griffeth LK, Rich KM, Dehdashti F, et al. Brain metastases from non-central nervous system tumors: evaluation with PET. Radiology. 1993;186:37-44.
7. Palm I, Hellwig D, Leutz M, et al. Brain metastases of lung cancer: diagnostic accuracy of positron emission tomography with fluorodeoxyglucose (FDG-PET) [in German]. Med Klin (Munich) 1999;94:224-227.
8. Chao ST, Suh JH, Raja S, Lee SY, Barnett G. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 2001;96:191-197.
9. Kim EE, Chung SK, Haynie TP, et al. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics 1992;12:269-279.
10. Kim DG, Kim CY, Paek SH, et al. Whole-body [18F]FDG PET in the management of metastatic brain tumours. Acta Neurochir (Wien) 1998;140:665-674.
11. Klee B, Law I, Hojgaard L, Kosteljanetz M. Detection of unknown primary tumours in patients with cerebral metastases using whole-body 18F-flouorodeoxyglucose positron emission tomography. Eur J Neurol 2002;9:657-662.
12. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409-1415.